NM_001379180.1:c.952G>A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_001379180.1(ESRRB):​c.952G>A​(p.Asp318Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,593,616 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00026 ( 1 hom., cov: 34)
Exomes 𝑓: 0.00013 ( 1 hom. )

Consequence

ESRRB
NM_001379180.1 missense

Scores

2
8
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 10.0

Publications

3 publications found
Variant links:
Genes affected
ESRRB (HGNC:3473): (estrogen related receptor beta) This gene encodes a protein with similarity to the estrogen receptor. Its function is unknown; however, a similar protein in mouse plays an essential role in placental development. [provided by RefSeq, Jul 2008]
ESRRB Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 35
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.024855167).
BP6
Variant 14-76491548-G-A is Benign according to our data. Variant chr14-76491548-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 228675.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000256 (39/152398) while in subpopulation AMR AF = 0.00137 (21/15310). AF 95% confidence interval is 0.000918. There are 1 homozygotes in GnomAd4. There are 13 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ESRRBNM_001379180.1 linkc.952G>A p.Asp318Asn missense_variant Exon 6 of 7 ENST00000644823.1 NP_001366109.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ESRRBENST00000644823.1 linkc.952G>A p.Asp318Asn missense_variant Exon 6 of 7 NM_001379180.1 ENSP00000493776.1 A0A2R8Y491

Frequencies

GnomAD3 genomes
AF:
0.000256
AC:
39
AN:
152280
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000723
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00137
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000211
AC:
46
AN:
217508
AF XY:
0.000180
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000965
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000929
Gnomad OTH exome
AF:
0.000902
GnomAD4 exome
AF:
0.000130
AC:
188
AN:
1441218
Hom.:
1
Cov.:
35
AF XY:
0.000108
AC XY:
77
AN XY:
714718
show subpopulations
African (AFR)
AF:
0.0000300
AC:
1
AN:
33350
American (AMR)
AF:
0.00110
AC:
45
AN:
40816
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39036
South Asian (SAS)
AF:
0.0000482
AC:
4
AN:
83010
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52006
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5194
European-Non Finnish (NFE)
AF:
0.000104
AC:
115
AN:
1102478
Other (OTH)
AF:
0.000385
AC:
23
AN:
59674
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000256
AC:
39
AN:
152398
Hom.:
1
Cov.:
34
AF XY:
0.000174
AC XY:
13
AN XY:
74524
show subpopulations
African (AFR)
AF:
0.0000721
AC:
3
AN:
41604
American (AMR)
AF:
0.00137
AC:
21
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68042
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000286
Hom.:
0
Bravo
AF:
0.000453
ExAC
AF:
0.000206
AC:
25

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Oct 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 08, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis indicates that this missense variant does not alter protein structure/function; Reported in a patient with Meniere disease in published literature (PMID: 30828346); This variant is associated with the following publications: (PMID: 30828346) -

not specified Uncertain:1
Mar 14, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Asp297Asn variant in ESRRB has not been previously reported in individuals with hearing loss, but has been identified in 9/3358 Latino chromosomes and 5/3 4372 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac .broadinstitute.org; dbSNP rs20134470). Although this variant has been seen in t he general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analyses do not provide s trong support for or against an impact to the protein. In summary, the clinical significance of the p.Asp297Asn variant is uncertain. -

Autosomal recessive nonsyndromic hearing loss 35 Uncertain:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.25
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.62
D;.;.;.
Eigen
Pathogenic
0.90
Eigen_PC
Pathogenic
0.92
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.96
D;.;D;D
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.025
T;T;T;T
MetaSVM
Benign
-0.55
T
MutationAssessor
Uncertain
2.4
.;M;.;M
PhyloP100
10
PrimateAI
Uncertain
0.74
T
PROVEAN
Uncertain
-2.4
N;N;.;N
REVEL
Uncertain
0.34
Sift
Benign
0.075
T;D;.;D
Sift4G
Benign
0.15
.;T;.;T
Polyphen
0.99
D;.;.;.
Vest4
0.74, 0.75
MVP
0.69
MPC
0.50
ClinPred
0.27
T
GERP RS
6.2
gMVP
0.63
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201344770; hg19: chr14-76957891; API